The Medical Devices sector report, “Collagens Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Collagens pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Collagens includes dressings that are typically made up of a combination of animal collagen and any other formulation (such as cellulose or alginates) for structural integrity, and sodium or calcium ions.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Collagens includes dressings that are typically made up of a combination of animal collagen and any other formulation (such as cellulose or alginates) for structural integrity, and sodium or calcium ions.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Collagens under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Collagens and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Collagens under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Collagens - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acro Biomedical Co Ltd
- Advanced Biotech Products Pvt Ltd
- Advanced Medical Solutions Group plc
- AGAM Biological Products
- Altach AG
- Altrazeal Life Sciences Inc
- Baxter International Inc
- Biovotec AS
- Collagen Solutions Ltd
- Collplant Biotechnologies Ltd
- Colzyx AB
- Conversion Energy Enterprises
- Covalon Technologies Ltd
- Ension, Inc.
- EternoGen Aesthetics LLC
- Gene Biotherapeutics Inc
- GeniPhys LLC
- Giant Biogene Holding Co Ltd
- Harbor MedTech Inc
- Holista CollTech Ltd
- Innocoll Technologies Ltd (Inactive)
- Jellagen Ltd
- Keranetics LLC
- Lattice Biologics Ltd
- Leader Biomedical Europe BV
- Medtronic Plc
- Michigan State University
- MiMedx Group Inc
- Nanotherapeutics Inc (Inactive)
- Orbsen Therapeutics Ltd
- PlasMedica Technologies Limited
- Purdue University
- Qinghai Chuangming Medical Equipment Co Ltd
- Shire Pharmaceuticals International UC
- Tel Aviv University
- VA Palo Alto Health Care System
- Wound Care Innovations LLC